Flunarizine Tablets
Intended to support migraine prophylaxis and developed to alleviate vertigo.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Sibelium
- Therapeutic class
Calcium Channel Blocker
- Pharmacological class
Piperazine derivative
- Contraindications
history of depression; extrapyramidal symptoms; parkinson's disease
- Precautions and warnings
may cause drowsiness; monitor weight gain; include regular breaks in treatment
- Minor side effects
somnolence; weight gain; fatigue
- Moderate side effects
depression; extrapyramidal disorder; insomnia
- Serious side effects
parkinsonism — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Intended to support migraine prophylaxis and developed to alleviate vertigo.
- Prescription status
POM
- Manufacturer
Janssen-Cilag
- Onset Time
2–4 weeks
- Duration
Ongoing prophylaxis
- Storage instructions
Store below 25°C, away from light and moisture.
- Drug interactions
alcohol; anticonvulsants
- Age restrictions
Consult physician for use in elderly.
- Pregnancy and breastfeeding
Use only if strictly necessary.
Mechanism of action
Flunarizine prevents cellular calcium overload by blocking calcium channels, which helps stabilize vascular smooth muscle and nerve cells against hypoxia and excessive vasoconstriction.
Flunarizine Tablets
Intended to support migraine prophylaxis and developed to alleviate vertigo.
Editorial Notes
- Active ingredient(s): Flunarizine
- Listed indication(s): Migraine Prophylaxis, Vertigo
Usually available as
- 180 tablets - 5 mg382-5-mg-15063
- 180 tablets - 10 mg382-10-mg-15058